Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| EPI Health, Inc | Location not on file | Makes it | Not inspected on record |
Recalls
- Apr 23, 2024 · Class II · EPI Health, LLC
CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
Lots: lot # T2300765- exp. 11/30/2025 lot# T2201702A-exp. 02/28/2025 lot# T2201699- exp. 2/28/2025 lot# T2201698- exp. 2/28/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Minocycline: every company that makes it
- Form
- tablet
- Strength
- 105 mg
- Approval
- NDA NDA209269
- On the market since
- Mar 15, 2019
- Package NDCs
71403-101-0571403-101-30- Official label
- DailyMed (National Library of Medicine), updated Nov 2, 2022
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?